Nov 9
GSHD · Goosehead Insurance, Inc.
$54.69
-0.87 (-1.56%)
At close · Nov 9
Return incl. dividend (before tax)
Market Cap
$1.94B
Shares
35.52M
Volume · Nov 9
345.84K
Avg daily vol (3M)
406.16K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$54.69
Open$55.55
Day$53.96–55.98
52W close$34.37–78.37
Avg vol 30d414K
Short int2.4M · 6.8% of shares · 5.8d
Short vol60%
Last earningsNov 9, 2026
DataJan 2020–Nov 2026
Filing10-Q · Jul 23
Up next
Feb 18, 2027
Est · unconfirmed
· in 14 wks
Latest documents
2026
Nov 9
Current report
8-K
Events of Nov 6
Financial results, Earlier financial statements no longer reliable
AI summary on its way
Jul 23
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $113.39M
▲ 20.6%
Net income $10.07M
▲ 95.4%
Jul 22
Jul 22
Current report
8-K
Financial results, Director or officer change, or executive pay
AI summary on its way
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$402.16M
Trailing 12 months
Net income (TTM)
$34.99M
Trailing 12 months
Revenue growth YoY
+20.6%
Year over year
Operating margin
23.3%
Trailing 12 months
P / E (TTM)
52.6
Trailing earnings · reciprocal yield 1.9%
FCF yield
4.0%
TTM · current market cap
Return on invested capital
42.9%
Trailing 12 months
Net cash
−$293.72M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-7.4%
Year over year · fewer shares
Price change (1Y)
-21.4%
Trailing year
Short interest
6.8%
Latest settlement · 5.8 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 25.6 · fear
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+9%
above
Price vs 50-day avg
+7%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
46%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+24%
trailing
6-month return
+32%
trailing
YTD return
−26%
this year
Relative strength
+30%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $51 › 200d $50 — 50d above 200d
Institutional flow
Accumulating
109 of 231 funds reported for Sep 30 · net +680.3K sh shares · +16 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.77% of shares out · ▼ -4.8% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
231 holders — mid 3-yr range
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+16%
Y/Y
EPS growth
−10%
Y/Y
Free cash flow
$86.1M
Valuation
P/E 55
rich
Buyback
$144.6M
remaining
Balance sheet
$258.1M
net debt
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−56%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jul 22, 2026
Total revenues
· full year 2026
Non-GAAP
Raised
12% – 19%
Apr 22, 2026
10% – 19%
changed to
Jul 22, 2026
12% – 19%
Total written premiums
· full year 2026
Non-GAAP
12% – 20%
Previous outlook
earlier release
· from the Earnings Call filed Apr 22, 2026
Still-open targets the latest release did not restate under the same label.
Client retention
· during the year
86%
Guided vs delivered
· last 6 settled
Total revenues
full year 2025
guided $350M – $385M
$365.3M
In line
Total revenues
full year 2024
guided $290M – $310M
$314.51M
Beat +4.8%
Total revenues
full year 2023
guided $260M – $267M
$261.28M
In line
Total revenues
for 2022
guided $194M – $205M
$209.39M
Beat +5.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+9%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
46%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $51 › 200d $50 — 50d above 200d
Institutional flow
Accumulating
109 of 231 funds reported for Sep 30 · net +680.3K sh shares · +16 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.77% of shares out · ▼ -4.8% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
231 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $34
Now $55 · 46%
Range high $78
vs 200-day avg +9%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $37.9M | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA Margin non-GAAP | 33% | Three Months Ended June 30, 2026 filing | — |
| Adjusted EPS non-GAAP | $0.64 | the three months ended June 30, 2026 filing | — |
| Ancillary Revenue non-GAAP | $16.3M | Three Months Ended June 30, 2026 filing | — |
| Core Revenue non-GAAP | $95.6M | Three Months Ended June 30, 2026 filing | — |
| Corporate sales Total Written Premium | 238.87M | Three Months Ended June 30, 2026 filing | — |
| Cost Recovery Revenue non-GAAP | $1.5M | Three Months Ended June 30, 2026 filing | — |
| Franchise locations onboarded | 10 | the three months ended June 30, 2026 filing | — |
| Franchise sales Total Written Premium | $1.1B | Three Months Ended June 30, 2026 filing | — |
| New Business Revenue | $22.1M | Three Months Ended June 30, 2026 filing | — |
| Renewal Revenue | $73.5M | Three Months Ended June 30, 2026 filing | — |
| Total Written Premiums | $1.34B | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance Brokers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GSHD
this stock
Goosehead Insurance, Inc.
|
$1.94B | -25.8% | +16.2% | 55.0 | 6.8% |
|
MRSH
Marsh & Mclennan Companies, Inc.
|
$97.18B | +10.2% | +10.3% | 24.5 | 1.4% |
|
AJG
Arthur J. Gallagher & Co.
|
$71.95B | +8.4% | +10.1% | 42.9 | 2.8% |
|
AON
Aon plc
|
$71.24B | -4.8% | +7.7% | 18.4 | 1.6% |
|
WTW
Willis Towers Watson PLC
|
$30.16B | -0.5% | -2.2% | 20.1 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GSHD | +6.5% | +24.4% | +32.4% | +14.9% | -25.8% |
| SPY | +0.1% | -3.3% | +2.6% | -0.4% | +10.4% |
| vs SPY | +6.4% | +27.7% | +29.8% | +15.3% | -36.1% |
Capital returns
Latest dividend
$5.91
/ share · ex Jan 21, 2025
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback program
· as of Jun 30, 2026
Authorized
—
Spent (derived)
—
Remaining
$144.60M
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1726978
CUSIP
38267D109
13F (30d)
112 filings
96 filers
Visit website
Investor relations